RevBio Advances Dental Implant Stabilization Trials
RevBio, Inc. announced that it has received regulatory and ethics committee approvals in multiple European countries to conduct its pivotal clinical trial for.
Todays Dental News
Todays Dental News
Innovative Bone Adhesive for Dental and Cranial Applications Secures Key Patent
The United States Patent and Trademark Office recently issued patent 12,178,937, entitled “Compositions and Methods for Adhesion to Surfaces,” which constitutes the 10th.
Industry News
RevBio Awarded a $2 Million Follow-On NIH Grant to Reduce Opioid Use and Addiction with TETRANITE
RevBio announced that it has received a grant from the National Institutes of Health through its Helping to End Addiction Long-term Initiative, or.
Industry News
RevBio Receives FDA Approval to Conduct its Second U.S.-Based Clinical Trial for Dental Implant Stabilization
RevBio announced that it has received approval from the U.S. Food and Drug Administration to commence a 20-patient clinical trial to assess the.
Industry News
RevBio is Awarded a $2 Million Grant
RevBio, Inc., announced that it has been awarded a $2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute.
Industry News
RevBio Receives a Strategic Investment from Pacific Dental Services to Support Ongoing Clinical Trials in Implant Dentistry
RevBio announced that it has received a strategic investment from Pacific Dental Services (PDS) to support the clinical development of its bone adhesive.
